# Safety,Tolerability,and Pharmacokinetics Profiles of GB001 Recombinant Peptide Spray in Healthy Subjects

> **NCT05125211** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Zhejiang Echon Biopharm Limited** · enrollment: 91 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** GB001 recombinant peptide spray
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05125211
- **Lead sponsor:** Zhejiang Echon Biopharm Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-08-08
- **Primary completion:** 2022-11-18
- **Final completion:** 2026-05-29
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2025-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05125211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05125211, "Safety,Tolerability,and Pharmacokinetics Profiles of GB001 Recombinant Peptide Spray in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05125211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*